drugset / Trial / NCT00638482

Dose-Dependent Effect of Thiazide in Dent's Disease Hypercalciuria

NCT00638482

Phase 2/3 Terminated 10 enrolled Assistance Publique - Hôpitaux de Paris
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Intrarenal calcifications (nephrocalcinosis) is present in Dent's disease and likely contribute to progression toward renal failure. In order to prevent this complication it is usually proposed to treat affected patients during childhood with high doses of thiazides.

Timeline

Start
2003-07
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 6.25 mg
Subject Hydrochlorothiazide Unknown 12.5 mg
Subject Hydrochlorothiazide Unknown 25 mg